Clinical trial
A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation
NCT01175655 is registered in ClinicalTrials.gov with The Prince Charles Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation
- Lead sponsor
- The Prince Charles Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- July 31, 2016
- Enrollment
- 10 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bronchiolitis obliterans, lung transplantation